Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

MAIA BIOTECHNOLOGY, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security    

Type    

  Security Class Title  

Fee

Calculation

or Carry

Forward

Rule

 

Amount    

Registered    

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price(1) (2)

  Fee Rate  

Amount of

Registration

Fee

                 
Fees to be Paid   Equity    

  Common shares, $0.0001        

  par value per share(2)

  Rule 457(o)                       $                   $5,750,000    $0.0001102    $633.65
                 
    Equity       Representative warrants(3)   Rule 457(g)        —    —   
                 
Fees to be Paid   Equity    

  Common shares issuable

  upon the exercise of the

  Representative’s warrants(4)

  Other      $                   $   359,375    $0.0001102    $  39.60
           
    Total Offering Amounts     $6,109,375      $673.25
           
    Total Fees Previously Paid        
           
    Total Fee Offset        
           
    Net Fee Due               $673.25

 

(1)

Includes shares of common stock of MAIA Biotechnology, Inc. (the “Company”), which the underwriters have the right to purchase to cover over-allotments. See “Underwriting.”

(2)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended.

(3)

No fee required pursuant to Rule 457(g).

(4)

We have agreed to issue to the representative of the underwriters (the “Representative”), upon the closing of this offering, warrants to purchase up to an aggregate number of shares of our common stock (the “Representative’s Warrants”) in an aggregate equal to five percent (5%) of the aggregate number of shares of common stock to be issued and sold in this offering) (the “Representative’s Warrants”). The Representative’s Warrants are exercisable at a per share price equal to 125% of the public offering price per share of the shares of common stock sold in this offering. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Representative’s Warrants is equal to 125% of $287,500 (which is equal to 5% of $5,750,000). See “Underwriting”.